Cargando…
Hydroxychloroquine for Treatment of SARS‐CoV‐2 Infection? Improving Our Confidence in a Model‐Based Approach to Dose Selection
Autores principales: | Arnold, Samuel L.M., Buckner, Frederick |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7262232/ https://www.ncbi.nlm.nih.gov/pubmed/32268005 http://dx.doi.org/10.1111/cts.12797 |
Ejemplares similares
-
What SARS-CoV-2 does to our brains
por: Aschman, Tom, et al.
Publicado: (2022) -
Approaches and Challenges in SARS-CoV-2 Vaccine Development
por: Dagotto, Gabriel, et al.
Publicado: (2020) -
Immune dysregulation and immunopathology induced by SARS-CoV-2 and related coronaviruses — are we our own worst enemy?
por: Wong, Lok-Yin Roy, et al.
Publicado: (2021) -
Is hydroxychloroquine beneficial for COVID-19 patients?
por: Li, Xing, et al.
Publicado: (2020) -
Superantigens and SARS-CoV-2
por: Hamdy, Adam, et al.
Publicado: (2022)